Sector portfolio · VC firm · United States
Keiretsu Capital's Biotech portfolio
Keiretsu Capital has backed 10 Biotech startups in rounds we track, $110M between them, shown by the stage each has reached. The best-funded is Evrys Bio.
Keiretsu Capital's whole portfolioKeiretsu Capital's profile
Funding by segment
- Stage not reported$88M8
- Series A$23M2
Where they are based
- United States9$103M
- Canada1$6.8M
United States
CanadaFounded
1 without a founding year on record.
Total raised
- Under $1M1
- $1M to $10M4
- $10M to $50M5
- $50M to $250M0
- $250M to $1B0
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
9 of 10 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States9
- Canada1
Startups by country, 2 countries in all.
Segment by segment
Stage not reported
8 startups · $88M raised
Evrys BioEvrys Bio is a pharmaceutical company for providing health care solutions to defend against the virus.United States$34M
b.well Connected Healthb.well Connected Health is a private healthcare technology company founded in 2015 by CEO Kristen Valdes.United States$20M
ActXActX is a dynamic venture that focuses on making patient genomic information truly useful in everyday medical practice.United States$11M
Salarius PharmaceuticalsSalarius Pharmaceuticals is an oncology-based biotechnology company developing new therapies to address gene dysregulation.United States$7.0M
Orion BiotechnologyOrion Biotechnology is a clinical-stage biotechnology company based in Ottawa, Canada, with research and development operations inCanada$6.8M
InmedixInmedix brings cloud-based clinical diagnostics and immuno-autonomics to medicine to improve outcomes in autoimmune diseases and beyond.United States$4.7M
Virion TherapeuticsVirion Therapeutics is a science-driven company developing innovative immune-based treatments for virally-associated cancers.United States$4.1M
Atrin PharmaceuticalsAtrin Pharmaceuticals is a privately held biopharmaceutical company that aims to change the way cancer is being treated.United States$100K
Series A
2 startups · $23M raised
Astarte MedicalAstarte Medical is a clinical intelligence company dedicated to precision medicine for preterm infants and children with medical complexity.United States$13M
HealionicsHealionics has developed a novel vascular graft, based on a platform biomaterial, offering improved vascular access for dialysis patients.United States$10M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Keiretsu Capital as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Keiretsu Capital?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.